Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer

Table 2 Hematological toxicity of neoadjuvant chemotherapy, n (%)

Items	mFLOT, n = 122		FOLFOX, SOX/XELOX, n = 75		Other1, n = 11
Grade	3	4	3	4	3	4
Anemia	41 (33.6)	15 (12.3)	18 (24)	9 (12)	6 (54.5)	3 (27.3)
Neutropenia	24 (19.7)	26 (21.3)	25 (33.3)	5 (6.7)	5 (45.5)	1 (9.1)
Febrile-neutropenia	6 (4.9)	0	1 (1.3)	0	0	0
Thrombocytopenia	8 (6.6)	4 (3.3)	8 (10.7)	0	0	5 (45.5)

¹Other regimen includes 10 cases of Docetaxel plus fluorouracil and 1 case of docetaxel monotherapy. mFLOT means Docetaxel 50-60 mg/m² + Oxaliplatin 85 mg/m² + Fluorouracil 2800 mg/m² intravenous injection over 48 h; every 2 wk. SOX means Oxaliplatin 130 mg/m² intravenous injection + Tegafur Gimeracil Oteracil Potassium Capsule 40-60 mg bid D1-D14; every 3 wk. XELOX means Oxaliplatin 130 mg/m² + Capecitabine 1000 mg/m² bid D1-D14; every 3 wk. FOLFOX means Oxaliplatin 85 mg/m² + Fluorouracil 2800 mg/m² continuous intravenous injection over 48 h; every 2 wk.